GTR Home > Tests > Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons)


Test order codeHelp: G-1012-01

Test name


Alzheimer: Apo-E, PSEN1, PSEN2, A2M and APP genes sequence analysis (select exons)

Purpose of the test


This is a clinical test intended for Help: Diagnosis



4 conditions tested. Click Indication tab for more information.


Molecular Genetics
CSequence analysis of the entire coding region
Bi-directional Sanger Sequence Analysis

Summary of what is tested

5 genes and variants. Click Methodology tab for more information.


Clinical validity


Not provided

Clinical utility


Not provided

How to order


Not provided

Practice guidelines

  • CCCDTD, 2014
    Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians.
  • ACMG/NSGC, 2011
    Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.
  • EFNS, 2010
    EFNS guidelines for the diagnosis and management of Alzheimer's disease.
  • AHRQ, 2010
    Preventing Alzheimer's disease and cognitive decline.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center